BiPER Therapeutics | €1M | 🧬 Biotech

Strasbourg-based BiPER Therapeutics raised €1 million to advance its lead cancer drug candidate into clinical trials. The company is developing oral small molecules that target BiP, a protein linked to cancer cell survival, using an approach designed to overstress diseased cells. Part of the funding will also support a new AI-enhanced R&D center in Tunisia.

Komia | €1.2M | 👨‍🍳 Food & Beverages

Lyon-based Komia raised €1.2 million in a round backed by Bpifrance, Réseau Entreprendre Rhône, and footballers Aurélien Tchouaméni and Jules Koundé. The startup provides software to help restaurants manage operations, track margins, and forecast demand. The funds will support team expansion and further development of its predictive tools.

Ventuno Biotech | €2M | 🧬 Biotech

Lyon-based Ventuno Biotech raised €2 million in a seed round combining €2 million in equity from Octalfa, Relyens Innovation Santé, and business angels and supported by a further €1 million in debt from Caisse d’Epargne Rhône Alpes and BNP Paribas Innovation. The startup is developing new immunotherapies that aim to help the immune system fight cancers resistant to current treatments.

Rob’Occ | €3M | 🚚 Robotics

Rob'Occ, based in Brens, raised €3 million from a group of Franco-Swiss business angels and regional investors including Occibot Industries and Tarn Capital Investissement. The startup builds assistant robots that automate tasks like internal transport in factories, shops, and warehouses. The funding will help it ramp up hiring and accelerate sales in France and Europe.

ReSoil | €4M | 🌱 Agriculture

Paris-based ReSoil raised €4 million from Banque des Territoires, INCO Ventures, and other private investors. The startup helps French farmers transition to regenerative agriculture by offering carbon tracking tools and financial incentives tied to improved environmental practices.

Veragrow | €4.5M | 🌱 Agriculture

Veragrow, based in Val-de-Reuil, raised €4.5 million from Odyssée Venture, Normandie Participations, CEN Innovation, and Groupe All Sun. The startup produces biostimulants made from worm compost to improve crop yields and soil health.

2501.AI | €8M | 🤖 AI

Paris-based 2501.ai has raised €8 million from Cusp Capital, Galion.exe, Axeleo Capital and several angel investors. The startup builds on-premise, multi-agent AI systems that automate real-time monitoring, diagnosis and incident remediation for mission-critical IT environments. The team, led by Alexandre Pereira and Alex Zhuk, is also expanding to New York as it scales internationally.

Sim&Cure | €10M | 🏥 Medtech

Montpellier-based Sim&Cure raised €10 million in an extension to their €3.1 million raise from April of this year. The new round is backed by Elaia, IT Translation Investissement, Sofilaro, and others and will support continued growth for Sim&Cure’s software that helps doctors plan brain aneurysm surgeries using AI and digital twins. The funding will be used for global expansion (especially in Asia) and to boost R&D and commercial growth efforts.

Bitstack | €12.9M | 🪙 Crypto

Paris-based Bitstack raised €12.9 million ($15 million) in a Series A round led by 13books Capital with participation from AG2R LA MONDIALE, Plug and Play Ventures, Serena, Stillmark, and Y Combinator. The startup, which was part of YC’s summer 2022 batch, offers a mobile app that lets users automatically round up everyday purchases and invest the difference in Bitcoin. The funds will support its expansion across Europe and the launch of a Bitcoin rewards debit card.

Spark Cleantech | €17M | 🌳 Cleantech

Paris-based Spark Cleantech has raised €17 million in Series A funding plus an additional €12 million in debt from 360 Capital, Taranis, the Île-de-France Reindustrialisation Fund and Asterion Ventures.The startup builds systems that split natural gas into hydrogen and solid carbon before it’s burned, allowing industrial sites to cut CO₂ emissions without changing their existing equipment. The new capital will support scale-up, certification of its carbon materials, and its first commercial deployments.

Axoltis Pharma | €18M | 🧬 Biotech

Clermont-Ferrand-based Axoltis Pharma raised €18 million to advance clinical trials of its ALS drug candidate, NX210c. The treatment aims to restore the blood-brain barrier in patients with amyotrophic lateral sclerosis, a neurodegenerative disease with limited therapeutic options. Results from its Phase II trial are expected in mid-2026.

Gradium | €60M | 🤖 AI

Paris-based Gradium raised €60 million in a massive seed round just three months after publicly launching. The spinoff from Kyutai’s open-science AI lab develops voice AI models that process audio directly and skip text transcription in an approach they say improves latency and expressiveness. Founded by ex-Meta and DeepMind researchers, Gradium targets developers with its API product and has seen early traction with gaming, customer service, and healthcare customers.

Brevo | €500M | 📧 CRM

Paris-based Brevo, which offers a cloud‑based CRM and customer‑engagement platform, raised €500 million ($583 million) in fresh funding that values the company at over €1 billion. The round, which is structured more like an exit, was led by General Atlantic and Oakley Capita and existing investor Partech fully exit with other historic investors Bridgepoint and Bpifrance both selling a portion of their shares. For more on the full structure of the deal, The French Tech Journal has more info here.